Our patients, our priority

Putting our patients first is what allowed Khiron Life Sciences to become the medical cannabis market leader in Latin America.

Our Goal in UK

Khiron Life Sciences UK was founded in October 2019 and has been working assiduously to provide best care possible to patients in the UK. That is why our primary goal is to facilitate access to high-quality cannabis-based pharmaceutical products.

Our team

Our team is composed of experienced professionals from of the European medical cannabis industry. We are working closely with the London-based leading independent scientific body, Drug Science, responsible for Project Twenty21, the largest medical cannabis patient registry in Europe.

Our patients, our priority

Putting our patients first is what allowed Khiron Life Sciences to become the medical cannabis market leader in Latin America.

Our Goal in UK

Khiron Life Sciences UK was founded in October 2019 and has been working assiduously to provide best care possible to patients in the UK. That is why our primary goal is to facilitate access to high-quality cannabis-based pharmaceutical products.

Our team

Our team is composed of experienced professionals from of the European medical cannabis industry. We are working closely with the London-based leading independent scientific body, Drug Science, responsible for Project Twenty21, the largest medical cannabis patient registry in Europe.

Management

Lernen Sie unser Management-Team kennen

franziska

Franziska Katterbach

Chief Legal Officer & Managing Director, Europe

tejinder

Tejinder Virk

President, Europe

frederic

Frederic Lammer

Director of Operations, Europe

guillermo

Dr. Guillermo Moreno-Sanz

Scientific and Medical Director, Europe

Who are our colleagues?

We would like to introduce ourselves.